US2006239959A1PendingUtilityA1

Method for treating hypercholesterolemia with polyallylamine polymers

55
Assignee: HOLMES-FARLEY STEPHEN RPriority: Jun 18, 1997Filed: Feb 1, 2006Published: Oct 26, 2006
Est. expiryJun 18, 2017(expired)· nominal 20-yr term from priority
A61P 3/06A61P 43/00A61P 9/10A61P 3/00A61K 31/785
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for removing bile salts from a patient that includes administering to the patient a therapeutically effective amount of a non-absorbable amine polymers characterized by a repeat unit having the formula: and salts thereof, where n is a positive integer and x is zero or an integer between 1 and about 4.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled)  
     
     
         16 . A method of removing bile salts from a patient comprising administering to said patient a therapeutically effective amount of cross-linked homopolyallylamine, 
 wherein    said cross-linked homopolyallylamine is cross-linked by a multifunctional crosslinking agent, and    said multifunctional crosslinking agent is present in an amount from 0.5-25% by weight, based upon the combined weight of allylamine repeat units and multifunctional crosslinking agent.    
     
     
         17 . The method of  claim 16  wherein said multifunctional crosslinking agent is present in an amount from about 2.5-20% by weight, based upon the combined weight of allylamine repeat units and multifunctional crosslinking agent.  
     
     
         18 . The method of  claim 16 , wherein the patient has a serum LDL level of at least 130 mg/dL.  
     
     
         19 . The method of  claim 16 , wherein the multifunctional crosslinking agent comprises epichlorohydrin.  
     
     
         20 . The method of  claim 16 , wherein the multifunctional crosslinking Agent is epichlorohydrin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.